Mechanisms of electroencephalographic and behavioral changes produced by parenteral L-DOPA.
D000818:Animals; D001919:Bradycardia / Q000139:chemically induced; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology*; D003672:Defecation / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000009:adverse effects*; D004569:Electroencephalography; D005133:Eye Movements / Q000187:drug effects; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D009069:Movement Disorders / Q000139:chemically induced; D009638:Norepinephrine / Q000009:adverse effects; D014839:Vomiting / Q000139:chemically induced
D004295:Dihydroxyphenylalanine; D009638:Norepinephrine